Immune checkpoint inhibitors in osteosarcoma: A hopeful and challenging future

• Main Authors: Zeng Zhang (Author), Xin Tan (Author), Zengxin Jiang (Author), Hao Wang (Author), Hengfeng Yuan (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Osteosarcoma (OS), the most common malignant tumor in the musculoskeletal system, mainly occurs in adolescents. OS results in high mortality and disability rates due to a fatal metastatic tendency and subsequent iatrogenic damage caused by surgery, radiotherapy and chemotherapy. Recently, immunother...